ArticleBreast cancer research and treatment2021

Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer.

Lei Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.